John W. Raff
Founder at Dovuro Seeds Pty Ltd.
John W. Raff active positions
Companies | Position | Start | End |
---|---|---|---|
Dovuro Seeds Pty Ltd.
Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Founder | 2011-01-04 | - |
Corporate Officer/Principal | - | 2011-01-04 | |
Nutrihealth Pty Ltd.
Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Founder | 2011-01-04 | - |
Corporate Officer/Principal | - | 2011-01-04 | |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Director/Board Member | - | - |
Career history of John W. Raff
Former positions of John W. Raff
Companies | Position | Start | End |
---|---|---|---|
STARPHARMA HOLDINGS LIMITED | Director/Board Member | 2009-08-04 | 2011-06-16 |
Chairman | - | 2009-08-04 | |
The Biomolecular Research Institute Ltd. | Corporate Officer/Principal | - | - |
BioMelbourne Network | Chairman | 2009-07-29 | - |
Farmacule BioIndustries Pty Ltd.
Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Director/Board Member | - | - |
Training of John W. Raff
University of Melbourne | Doctorate Degree |
Statistics
International
Australia | 9 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chairman | 2 |
Sectoral
Health Technology | 3 |
Process Industries | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
STARPHARMA HOLDINGS LIMITED | Health Technology |
Private companies | 6 |
---|---|
The Biomolecular Research Institute Ltd. | |
Dovuro Seeds Pty Ltd.
Dovuro Seeds Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Dovuro Seeds Pty Ltd. is an Australian company that produces and wholesales canola seeds. The company is based in Horsham, Australia. The company was founded by John W. Raff. Dovuro Seeds was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
Nutrihealth Pty Ltd.
Nutrihealth Pty Ltd. Agricultural Commodities/MillingProcess Industries Part of Nufarm Ltd., Nutrihealth Pty Ltd. is an Australian company that produces grains and agricultural products. The company was founded by John W. Raff. Nutrihealth was acquired by Nufarm Ltd. on April 26, 2006. | Process Industries |
Farmacule BioIndustries Pty Ltd.
Farmacule BioIndustries Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Farmacule BioIndustries Pty Ltd. Developed industrial and therapeutic proteins and biofuels. It engaged in developing molecular farming technology to produce proteins, biofuels and bioplastics in plants for various industrial, therapeutic and diagnostic applications. The company was founded in 2001 and was headquartered in Altona North, Australia. | Commercial Services |
BioMelbourne Network | |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |
- Stock Market
- Insiders
- John W. Raff
- Experience